Events

Search this date backward
Format: Jun 05, 2020
April
08
Wednesday
2020

On April 8, 2020, from 12:15 pm – 1:15 pm Eastern Time, the U.S. Food and Drug Administration (FDA) will host a virtual Town Hall for clinical laboratories and commercial manufacturers that are developing or have developed diagnostic tests for SAR-CoV-2.

April
08
Wednesday
2020

BioProcessing Virtual Event

Virtual Conference

LabRoots is pleased to announce the 2nd Annual BioProcessing Virtual Event!

April
08
Wednesday
2020

Join CFA Society Cleveland and ARK Invest for a Live Webinar
ARK, Sam Korus, Analyst, April 8, 2020, 12:00PM
Please use the link in your confirmation email to register for login information prior to the meeting

April
07
Tuesday
2020

The Technology Partnerships Ofifce (TPO) of the National Institue of Standards and Technology (NIST) presents "Tech Transfer 101 Training: Recognizing and Reporting Technological Innovation and Inventions," on April 7 from 2 to 3 pm Eastern time.

April
07
Tuesday
2020

As a world leader in high-performance and advanced materials research, the National Energy Technology Laboratory's Crosscutting High Performance Materials Program presents the Regional Work Force Initiative (RWFI) Energy 101 Series, which shares how the Lab’s work and expertise translates to

April
07
Tuesday
2020

DARPA will host a Proposers’ Day in support of upcoming DARPA BAA HR001120S0042, Ocean of Things (OoT) Advanced Data Analytics Phase 2, on Tuesday, April 07, 2020 from 10:30 AM to 5:00 PM, ET.

April
06
Monday
2020

The current health crisis has created unprecedented challenges. Although Frost & Sullivan has made the decision to shift its 2020 event dates, they remain committed to being a partner in your desire to learn, grow and innovate.

April
04
Saturday
2020

Update: The circumstances around novel coronavirus (COVID-19) have been fast evolving.

April
02
Thursday
2020

During this COCA (Clinician Outreach and Communication Activity) Call, clinicians will provide an overview of the clinical characteristics of COVID-19 patients, including case presentations of critically ill adults and clinical management challenges, and summarize recently published guidelines on

April
02
Thursday
2020

With the novel coronavirus spreading both fear and illness across the world, it is a worthwhile exercise to look at the patent landscape of antiviral vaccines.

Pages